
==== Front
J Transl Med
J Transl Med
Journal of Translational Medicine
1479-5876
BioMed Central London

5348
10.1186/s12967-024-05348-8
Correction
Correction: Real‑world data suggest effectiveness of the allogeneic mesenchymal stromal cells preparation MSC‑FFM in ruxolitinib‑refractory acute graft‑versus‑host disease
Bonig Halvard 123
Verbeek Mareike 4
Herhaus Peter 4
Braitsch Krischan 4
Beutel Gernot 5
Schmid Christoph 6
Müller Nadine 7
Bug Gesine 8
Döring Michaela 9
von Stackelberg Arend 10
Tischer Johanna 11
Ayuk Francis 12
Wulf Gerald 13
Holtick Udo 14
Pfeffermann Lisa‑Marie 2
Jahrsdörfer Bernd 15
Schrezenmeier Hubert 15
Kuci Selim 16
Kuci Zyrafete 16
Zens Anke 17
Tribanek Michael 17
Zeiser Robert 18
Huenecke Sabine 19
Bader Peter p.bader@em.uni-frankfurt.de

19
1 https://ror.org/04cvxnb49 grid.7839.5 0000 0004 1936 9721 Faculty of Medicine, Institute for Transfusion Medicine and Immunohematology, Goethe University, Frankfurt, Germany
2 German Red Cross Blood Service BaWüHe, Institute Frankfurt, Frankfurt, Germany
3 https://ror.org/00cvxb145 grid.34477.33 0000 0001 2298 6657 Department of Medicine, Division of Hematology, University of Washington, Seattle, WA USA
4 grid.6936.a 0000000123222966 School of Medicine, Technical University Munich, Klinikum Rechts Der Isar, Clinic and Policlinic for Internal Medicine III, Munich, Germany
5 https://ror.org/00f2yqf98 grid.10423.34 0000 0000 9529 9877 Department of Hematology, and Stem Cell Transplantation, Hemostasis, Oncology, Hannover Medical School, Hannover, Germany
6 grid.7307.3 0000 0001 2108 9006 Augsburg University Hospital and Medical Faculty, Augsburg, Germany
7 https://ror.org/05sxbyd35 grid.411778.c 0000 0001 2162 1728 Universitätsklinikum Mannheim, Mannheim, Germany
8 https://ror.org/04cvxnb49 grid.7839.5 0000 0004 1936 9721 Department of Medicine 2, University Hospital, Goethe University, Frankfurt, Germany
9 grid.488549.c Universitätsklinik Für Kinder Und Jugendmedizin, Tübingen, Germany
10 https://ror.org/001w7jn25 grid.6363.0 0000 0001 2218 4662 Charité, Universitätsmedizin Berlin, Berlin, Germany
11 grid.5252.0 0000 0004 1936 973X Department of Medicine III, LMU University Hospital, LMU Munich, Munich, Germany
12 grid.13648.38 0000 0001 2180 3484 Klinik Für Stammzelltransplantation, Universitätsklinikum, Hamburg, Germany
13 https://ror.org/021ft0n22 grid.411984.1 0000 0001 0482 5331 Hämatologie Und Medizinische Onkologie, Universitätsmedizin Göttingen, Göttingen, Germany
14 https://ror.org/05mxhda18 grid.411097.a 0000 0000 8852 305X Universitätsklinikum Köln, Cologne, Germany
15 https://ror.org/032000t02 grid.6582.9 0000 0004 1936 9748 Institute for Clinical Transfusion Medicine and Immunogenetics, University of Ulm, Ulm, Germany
16 https://ror.org/04cvxnb49 grid.7839.5 0000 0004 1936 9721 Department of Pediatrics, Division for Stem Cell Transplantation and Immunology, Goethe University, Frankfurt, Germany
17 Medac Gesellschaft Für Klinische Spezialpräparate mbH, Wedel, Germany
18 https://ror.org/03vzbgh69 grid.7708.8 0000 0000 9428 7911 Department Innere Medizin, Klinik Für Innere Medizin I, Universitätsklinikum Freiburg, Freiburg, Germany
19 https://ror.org/04cvxnb49 grid.7839.5 0000 0004 1936 9721 Department of Pediatrics, Division of Stem Cell Transplantation and Immunology, Goethe University Frankfurt, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany
13 6 2024
13 6 2024
2024
22 566© The Author(s) 2024
https://creativecommons.org/licenses/by/4.0/ Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
issue-copyright-statement© BioMed Central Ltd., part of Springer Nature 2024
==== Body
pmc Correction: Journal of Translational Medicine (2023) 21:837 10.1186/s12967-023-04731-1

Following publication of the original article [1], we have been notified that the author’s last name was published incorrectly.

It is now:

Krischan Braitssch

It should be:

Krischan Braitsch

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
==== Refs
Reference

1. Bonig H Verbeek M Herhaus P Braitsch K Beutel G Schmid C Müller N Bug G Döring M von Stackelberg A Tischer J Ayuk F Wulf G Holtick U Pfeffermann L-M Jahrsdörfer B Schrezenmeier H Kuci S Zens A Tribanek M Zeiser R Huenecke S Bader P Real-world data suggest effectiveness of the allogeneic mesenchymal stromal cells preparation MSC-FFM in ruxolitinib-refractory acute graft-versus-host disease J Transl Med 2023 21 837 10.1186/s12967-023-04731-1 37990219
